MedTrace Logo

Percutaneous Left Stellate Ganglion Block In Out-of-hospital Cardiac Arrest Due to Refractory VEntricular Arrhythmias (LIVE Study)

NCT04168970 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2026-08-12

No results posted yet for this study

Summary

This is an observational, prospective study to verify the feasibility and practicability of percutaneous stellate ganglion block (PSGB) in patient suffering from a refractory out-of-hospital cardiac arrest (OHCA) due to a shockable rhythm and the eventual occurrence of complication related to it. The study will also assess the rate of ventricular fibrillation termination and the return of spontaneous circulation (ROSC) until admission and transfer of care to the receiving hospital is higher in the patients treated with PSGB as compared to historical controls.

Conditions

  • Out-Of-Hospital Cardiac Arrest
  • Ventricular Fibrillation Sustained
  • Shockable Rhythm
  • Medical Etiology
  • Refractory Ventricular Arrhythmias

Interventions

PROCEDURE

PSGB

Percutaneous stellate ganglion block: injection of 10 mL of local anaesthetic (lidocaine 2%) at the C6 level using the anatomic technique or the echo-guided technique The anaesthetic that will be used for PSGB is lidocaine.

Sponsors & Collaborators

  • University of Pavia

    collaborator OTHER

  • AREU - Agenzia Regionale Emergenza Urgenza

    collaborator UNKNOWN

  • Fondazione IRCCS Policlinico San Matteo di Pavia

    lead OTHER

Principal Investigators

  • Simone Savastano, MD · Cardiology Department, Fondazione IRCCS Policlinico San Matteo of Pavia (Italy)

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-12
Primary Completion
2025-12-31
Completion
2026-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04168970 on ClinicalTrials.gov